Scientific Research Facilities

The Department’s world-leading scientific research and specialist facilities provide essential support, expertise and knowledge to our research programmes. They afford the added value of partnership and expert advice in developing experiments, designing equipment, maintaining cutting edge technology and providing clinical support. We have invested heavily in these facilities to underpin the expanding Department and plug the gaps in support for our key areas of focus in cancer research. We also have strong links with other parts of the University and also tap into local expertise in neighbouring University facilities such as the Target Discovery Institute.

Bioanalysis

Supporting academic research within and outside of the university, we provide specialist analytical chemistry support in the majority through HPLC-MS or HPLC-MS-MS techniques with additional UV-visible absorbance and fluorescence detection abilities.

Early Phase Clinical Trials Unit

The Early Phase Clinical Trials Unit (EPCTU) aims to support the translation of research findings in to clinical practice.

Flow Cytometry

Flow Cytometry is a technology enabling the measurement of numerous parameters, via fluoroescence signalling, in your suspension sample of cells/particles.

Live Tissue Facility

The Live Tissue Facility is designed to boost the translational impact of oncological research without users having to independently create ethics applications and collection logistics.

Mechanical Workshop

The Mechanical Workshop delivers an on-site fabrication facility for custom-made, precision mechanical items for use in scientific research.

Microscopy

The Microscopy SRF aims to provide research groups with imaging technologies to investigate cellular processes both in vitro and in vivo.

Oncology Clinical Trials Office (OCTO)

The Oncology Clinical Trials Office (OCTO) provides clinical trial management support to investigators across the CRUK Oxford Centre to manage trials from concept to completion.

PET Radiochemistry and Radiopharmacy (PROx)

The PET Radiochemistry and Radiopharmacy core supports radiochemistry-dependent research programmes and provide GMP-grade PET radiopharmaceuticals for clinical trials.

Pre-Clinical Imaging

State-of-the art platforms for in vivo study of disease models

Proteomics

Proteomics studies proteins on a large scale. Proteins are vital to living organisms and their multi-functional characteristics act as potential targets for drug therapies. Therefore, proteomics can be used for biomarker and target discovery, drug profiling and target validation.